|
|
 |
|
Viewing report
|
|
|
|
Epidemiology: COPD - Aging Population and Stable Smoking Rates to Raise Case Numbers
Datamonitor, Aug 2011, Pages: 43
In 2010, Datamonitor estimates that there were about 69.5 million total prevalent cases of chronic obstructive pulmonary disease (COPD) in people aged over 40 in the seven major markets(the US, Japan, France, Germany, Italy, Spain, and the UK). Approximately 54% of cases were mild, 38% were moderate, and 8% were severe or very severe.
Features and benefits
- Gain insight into market potential, including a robust 10-year epidemiology forecast of chronic obstructive pulmonary disease prevalent cases.
- Understand the key epidemiologic risk factors associated with chronic obstructive pulmonary disease.
Highlights
- Between 2010 and 2020, Datamonitor expects to see a significant increase in the number of total prevalent cases of COPD in those over age 40 in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK), from 69.5 million cases to 79.5 million cases. The largest increase will be in the US and the smallest in Germany.
- Datamonitor estimates that the largest number of cases of COPD will be in those over age 70, especially in men, due to the fact that COPD prevalence rates increase with age and men are more likely to be smokers. Of the prevalent cases, 11% will be in those aged 40–49, 21% in those aged 50–59, 25% in those aged 60–69, and 42% in those aged over 70.
- Datamonitor estimates that in 2010, the majority of COPD cases in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK) were mild cases. Approximately 54% of cases were mild, 38% were moderate, and 8% were severe or very severe.
Your key questions answered
- What are the most robust sources for chronic obstructive pulmonary disease prevalence data?
- How will the patient population change through to 2020 in the US, Japan, and the five major EU markets (France, Germany, Italy, Spain, and the UK)?
- How do changes in population structure and risk factors affect the trend in prevalent chronic obstructive pulmonary disease cases?
|
|
|
|
